<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346901</article-id>
      <article-id pub-id-type="pmc">3875978</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132427</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary cutaneous centrofollicular lymphoma with a good response to
radiotherapy<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Linfoma centrofolicular cut&#xE2;neo prim&#xE1;rio com boa resposta a
radioterapia</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Camargo</surname>
            <given-names>Cl&#xE1;udia Medeiros dos Santos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bomm</surname>
            <given-names>Lislaine</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abraham</surname>
            <given-names>Leonardo Spagnol</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Daher</surname>
            <given-names>Rafael</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Scotelaro</surname>
            <given-names>Maria de F&#xE1;tima Guimar&#xE3;es</given-names>
          </name>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abulafia</surname>
            <given-names>Luna Azulay</given-names>
          </name>
          <xref ref-type="aff" rid="aff06">6</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD - Graduate student in Dermatology at Hospital Universit&#xE1;rio Pedro
Ernesto - Universidade do Estado do Rio de Janeiro (HUPE-UERJ) - Rio de Janeiro (RJ),
Brazil.</aff>
      <aff id="aff02"><label>2</label> Dermatologist - Private Clinic - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff03"><label>3</label> MD, Master's Degree program student - Volunteer dermatologist at
Hospital Universit&#xE1;rio de Bras&#xED;lia - Universidade de Bras&#xED;lia (HUB-UnB) - Bras&#xED;lia (DF),
Brazil.</aff>
      <aff id="aff04"><label>4</label> MD, Radiotherapist in charge of the Radiotherapy Service at Hospital
Universit&#xE1;rio Pedro Ernesto - Universidade do Estado do Rio de Janeiro (HUPE-UERJ) - Rio
de Janeiro (RJ), Brazil.</aff>
      <aff id="aff05"><label>5</label> MD, PhD - Professor at the Dermatopathology Department of Hospital
Universit&#xE1;rio Pedro Ernesto - Universidade do Estado do Rio de Janeiro (HUPE-UERJ) - Rio
de Janeiro (RJ), Brazil.</aff>
      <aff id="aff06"><label>6</label> MD, PhD - Professor at the Dermatology Department of Hospital
Universit&#xE1;rio Pedro Ernesto - Universidade do Estado do Rio de Janeiro (HUPE-UERJ) - Rio
de Janeiro (RJ), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Cl&#xE1;udia Medeiros dos Santos Camargo, Avenida 28 de
Setembro, 77 -Vila isabel, 20551-080 - Rio de Janeiro - RJ, Brazil. E-mail:
<email>mdsc.claudia@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>136</fpage>
      <lpage>138</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>1</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Primary cutaneous lymphomas have different clinical behavior and prognosis than
systemic lymphomas of similar histological subtype. About 30% of non-Hodgkin
lymphomas involve extranodal tissues, the skin being the second most affected body
organ after the gastrointestinal tract (approximately 18%). According to the EORTC
(European Organization for Research and Treatment of Cancer) classification, the
lymphoma centrofollicular is indolent, since the lesions increase in size slowly over
the years and spread to extracutaneous sites is uncommon. Based on this, radiotherapy
has been considered the treatment of choice by many studies. We present the case of a
patient who had cutaneous centrofollicular scalp lymphoma for 1 year and showed good
response to radiotherapy.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Os linfomas cut&#xE2;neos prim&#xE1;rios t&#xEA;m comportamento cl&#xED;nico e progn&#xF3;stico diferente dos
linfomas sist&#xEA;micos de subtipo histol&#xF3;gico semelhante. Cerca de 30% dos linfomas
n&#xE3;o-Hodgkin acometem tecidos extranodais, sendo a pele o segundo &#xF3;rg&#xE3;o mais envolvido
ap&#xF3;s o trato gastrointestinal (aproximadamente 18%). De acordo com a classifica&#xE7;&#xE3;o
EORTC (European Organization for Research and Treatment of Cancer), o linfoma
centrofolicular cut&#xE2;neo &#xE9; indolente, uma vez que as les&#xF5;es aumentam de tamanho
lentamente ao longo dos anos e a dissemina&#xE7;&#xE3;o para sitios extracut&#xE2;neos &#xE9; incomum.
Com base nisso, a radioterapia tem sido apontada como o tratamento de primeira
escolha por muitos estudos. Apresentamos um caso de paciente com linfoma cut&#xE2;neo
centrofolicular no couro cabeludo h&#xE1; 1 ano e que apresentou boa resposta &#xE0;
radioterapia.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>B-Lymphocytes</kwd>
        <kwd>Lymphoma</kwd>
        <kwd>Lymphoma, B-cell</kwd>
        <kwd>Lymphoma, follicular</kwd>
        <kwd>Radiotherapy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Primary cutaneous lymphomas frequently have clinical behavior and prognosis different
than systemic lymphomas of similar histological subtype. About 30% of the non-Hodgkin
lymphomas affect extranodal tissues, the skin being the second most affected organ after
the gastrointestinal tract, or around 18% of all lymphomas.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> According to the EORTC classification (Cutaneous Lymphoma
Study Group of the European Organization for Research and 136 Treatment of Cancer), the
cutaneous centrofollicular lymphoma is a B-cell indolent lymphoma, since the lesions
grow slowly in size over the years and dissemination to extracutaneous sites is
uncommon.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> With that in mind,
radiotherapy has been referred as the first-choice treatment by many studies.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup>
The case of a patient with cutaneous centrofollicular lymphoma on the scalp with one
year of evolution is presented, which showed good response to radiotherapy.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 45 year-old white male, previously healthy, presented infiltrated plaques and
coalescent nodules on the left parietal region one year ago. He reported history of
local trauma six months before the onset of the lesion. He denied local or systemic
symptomatology (fever, night sweat or weight loss). On the dermatological exam were
found plaques and erythematous nodules of hard consistency, measuring about 8x4cm (<xref ref-type="fig" rid="f01">Figure 1</xref>). Palpable lymphadenopathy was absent. The
histopathological exam demonstrated a large diffuse dermal infiltrate that spared the
epidermis, with a partial follicular component (<xref ref-type="fig" rid="f02">Figure
2</xref>). The infiltrate was composed of a population of central follicle cells,
predominantly with multilobed nuclei, associated with large centroblasts and mixed
centrocytes and surrounded by a great quantity of small reactive T lymphocytes (<xref ref-type="fig" rid="f03">Figures 3</xref> and <xref ref-type="fig" rid="f04">4</xref>). </p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Erythematous Plaques and nodes, of hard consistency, measuring about 8x4 cm</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0136-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Large diffuse dermal infiltrate that spared the epidermis, with a partial
follicular component</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0136-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Multilobed nuclei, associated with large centroblasts and centrocytes</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0136-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Dermal infiltrate in higher magnification (100X)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0136-g04"/>
      </fig>
      <p>Immunohistochemistry was positive for CD5 and CD20 and negative for CD30. After the
centrofollicular lymphoma diagnosis, the patient was referred for hematologic evaluation
for research on systemic disease, which was negative; the classification was TNM TxN0M0.
He was submitted to radiotherapy with 3,060 cGy in 17 fractions on the scalp lesion,
with the 9 MeV direct electronic fields technique for 25 days, with good local response.
</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The cutaneous B-cell lymphomas represent 25% of cutaneous lymphomas. By the new
WHO-EORTC classification, these are divided into primary cutaneous centrofollicular
lymphoma, primary cutaneous marginal zone lymphoma and primary cutaneous large cell
lymphoma leg type.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup> The primary cutaneous centrofollicular lymphoma is a
relatively common lymphoma, characterized by the neoplastic proliferation of centrocytes
and centroblasts confined to the skin. The survival rate for this kind of lymphoma is
95% in 5 years, its prognosis being very favorable with low probability of
extracutaneous dissemination.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup> Clinically, they present as plaques or
nodes, solitary or grouped, being either normochromic or erythematous. Their favorite
sites are the head (front and scalp) and dorsum. Recurrences are observed in about 50%
of the cases, but dissemination to internal organs is rare.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> The histological exam is characterized by a pattern of
diffuse and/or follicular growth findings, composed of a variable mix of small and/or
big neoplastic cleaved cells (centroblasts), aside from immunoblasts, small lymphocytes,
histiocytes, eosinophils and plasma cells. Sometimes there may be reactive lymphoid
follicles resembling germinal centers, which, many times, hinders the differential
diagnosis with pseudo lymphomas.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup> The immunohistochemistry of tumor cells
reveals CD20, CD79a, CD10 and bcl-6 neoplastic cells masked as positive. Markers for
CD5, CD43 and bcl-2 are rarely positive. Since the cutaneous metastases of nodal
follicular lymphoma strongly express bcl-2 and CD10 proteins, the differential diagnosis
can be done between these and the primary cutaneous lymphomas.<sup><xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup> Lymphomas are
neoplasms that are very sensitive to ionizing radiation. Lymphoma sensitivity is usually
greater than that of the local surrounding tissue, which makes them very different from
other solid neoplasms.<sup><xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r07">7</xref></sup> There is little data about the
dose-response of radiotherapy for non-Hodgkin lymphomas. Studies demonstrate that for
the cutaneous centrofollicular lymphoma radiotherapy is the <italic>first</italic>-line
<italic>treatment</italic> of <italic>choice</italic>. The 25-35Gy dose is able to
control the disease more than 90%, the radiation field being a little larger than the
tumor so that non-visible lesions are also treated.<sup><xref ref-type="bibr" rid="r07">7</xref></sup> Other treatments indicated are surgical excision of small lesions;
for too extensive cutaneous lesions and extracutaneous disease, chemotherapy is
indicated. The therapeutic efficiency of anti-CD20 antibody, intralesional or systemic,
has recently been demonstrated.<sup><xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r07">7</xref></sup> Our patient presented excellent response
to radiotherapy, with complete resolution of the cutaneous lesion, presenting only an
alopecia plaque on the lesion's site (<xref ref-type="fig" rid="f05">Figure
5</xref>).</p>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Complete resolution of cutaneous lesion, presenting only cicatricial alopecia
plaque on the site</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0136-g05"/>
      </fig>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work carried out at the Pedro Ernesto University Hospital - State University of Rio
de Janeiro (HUPE-UERJ) - Rio de Janeiro (RJ), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moricz</surname>
              <given-names>CZM</given-names>
            </name>
            <name>
              <surname>Sanches JR</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Processos linfoproliferativos da pele. Parte -1 Linfomas
cut&#xE2;neos de c&#xE9;lulas B</article-title>
          <source>An Bras Dermatol</source>
          <year>2005</year>
          <volume>80</volume>
          <fpage>461</fpage>
          <lpage>471</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Senff</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Noordijk</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Bagot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Berti</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cerroni</surname>
              <given-names>L</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>European Organization for Research and Treatment of Cancer and
International Society for Cutaneous Lymphoma consensus recommendations for the
management of cutaneous B-cell lymphomas</article-title>
          <source>Blood</source>
          <year>2008</year>
          <volume>112</volume>
          <fpage>1600</fpage>
          <lpage>1609</lpage>
          <pub-id pub-id-type="pmid">18567836</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Glusac</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>McNiff</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Heald</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>DL</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Primary Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A
Comparison of the European Organization for Research and Treatment of Cancer and
the WHO Classification Systems</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>634</fpage>
          <lpage>639</lpage>
          <pub-id pub-id-type="pmid">14966086</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pandolfino</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Kuzel</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Guitart</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Primary cutaneous B-cell lymphoma: Review and current
concepts</article-title>
          <source>J Clin Oncol</source>
          <year>2000</year>
          <volume>18</volume>
          <fpage>2152</fpage>
          <lpage>2168</lpage>
          <pub-id pub-id-type="pmid">10811681</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergman</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Pseudolymphoma and cutaneous lymphoma: facts and
controversies</article-title>
          <source>Clin Dermatol</source>
          <year>2010</year>
          <volume>28</volume>
          <fpage>568</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="pmid">20797521</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kirova</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Piedbois</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Le Bourgeois</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Radiotherapy in the management of cutaneous B-cell lymphoma: Our
experience in 25 cases</article-title>
          <source>Radiother Oncol</source>
          <year>1999</year>
          <volume>52</volume>
          <fpage>15</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">10577681</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Halperin</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Brady</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Wazer</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Freeman</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Prosnitz</surname>
              <given-names>LR</given-names>
            </name>
          </person-group>
          <source>Principles and Practice of Radiation Oncology</source>
          <edition> 5th. ed </edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
          <year>2007</year>
          <fpage>1748</fpage>
          <lpage>1776</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
